Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)

CONCLUSIONS: OAC users in our study had more comorbidities and were older than non-users, well known risks for hospitalization being confirmed with our results. We also found in our study that OAC exposure was not associated to an increased risk in the mortality rate, and it was associated with higher risks of hospital admission and thromboembolic events, although we cannot assess the effect of the interventions applied during hospital admission on the outcomes studied, as our database is a PHC database.TRIAL REGISTRATION: EUPAS register: EUPAS37205 .PMID:35676639 | PMC:PMC9174624 | DOI:10.1186/s12875-022-01752-5
Source: Primary Care - Category: Primary Care Authors: Source Type: research